Actively Recruiting
Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
Led by University Hospital Muenster · Updated on 2025-06-13
200
Participants Needed
1
Research Sites
79 weeks
Total Duration
On this page
Sponsors
U
University Hospital Muenster
Lead Sponsor
U
University Hospital Munich
Collaborating Sponsor
AI-Summary
What this Trial Is About
The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.
CONDITIONS
Official Title
Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years or older
- Patients with advanced malignant tumor disease
- Patients with advanced chronic obstructive pulmonary disease
- Patients with advanced disease and limited life expectancy (approximately 12 months)
- Receiving further care in the Specialized Outpatient Palliative Care Service Muenster (prospective data)
- Sufficient understanding of German to understand information and consent forms
You will not qualify if you...
- Unable to understand the information and consent form
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Muenster
Münster, North Rhine-Westphalia, Germany, 48149
Actively Recruiting
Research Team
C
Christoph Klaas, Dr. rer. nat.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here